Sign in
4

Changes in Ownership

AIM ImmunoTech Inc. Filed Acc 0001450324-22-000004

CEO & President acquired 32,895 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Equels Thomas K · CEO & President

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2022-07-18 Grant or award : show line 1 in the form +32,895 $0.76 $25,000 382,704 D
Loading xslF345X03/primary_doc.xml…